Silverarc Capital Management
YARW icon

Silverarc Capital Management’s Yarrow Bioscience YARW Stock Holding History

Silverarc Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.8M Buy
+301,919
New +$10.3M 0.8% 34
2024
Q4 		– Sell
-1,536
Closed -$144K – 81
2024
Q3 		$144K Sell
1,536
-7,812
-84% -$740K 0.03% 70
2024
Q2 		$921K Buy
9,348
+7,620
+441% +$950K 0.22% 58
2024
Q1 		$265K Buy
+1,728
New +$186K 0.07% 72
2021
Q1 		– Sell
-97
Closed -$552K – 102
2020
Q4 		$552K Buy
+97
New +$610K 0.32% 69

Other funds holding YARW

SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Spruce Street Capital
Spruce Street Capital New York $629M AUM 210.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Monashee Investment Management
Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

Silverarc Capital Management's YARW Position: Q3 2026 in Review

Silverarc Capital Management opened a new position in Yarrow Bioscience (YARW) in Q3 2026: 301,919 shares worth $6.8M. The stake represents 0.8% of the portfolio and ranks #34 among its holdings. This is a return to the name: Silverarc Capital Management previously reported a position in YARW as recently as Q3 2024.

Silverarc Capital Management first reported a position in YARW in Q4 2020 and has held it in 5 quarters since. 25 funds tracked by Wall St. Rank hold YARW as of Q3 2026.

  • Silverarc Capital Management held 301,919 shares of Yarrow Bioscience worth $6.8M as of Q3 2026.
  • Yarrow Bioscience was a new Silverarc Capital Management position in Q3 2026.
  • Yarrow Bioscience made up 0.8% of Silverarc Capital Management's portfolio in Q3 2026, its #34 holding.
  • Silverarc Capital Management first reported a position in Yarrow Bioscience in Q4 2020 and has held it in 5 quarters since.
  • 25 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2026.

Based on Silverarc Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.